Abstract Background and Purpose Intracranial atherosclerosis is a common cause of stroke
worldwide. It results in ischemic stroke due to different mechanisms including artery‐to …

Background and Purpose—Although recent trials have suggested that stenting is worse than
medical therapy for patients with severe symptomatic intracranial atherosclerotic stenosis, it …

Background and purpose A multicentre prospective registry study of individually tailored
stenting for a patient with symptomatic intracranial atherosclerotic stenosis (ICAS) combined …

Background The outcome of deploying balloon-mounted stents for symptomatic intracranial
atherosclerotic stenosis (ICAS) has not been fully investigated. In this study we evaluate the …

Objectives To evaluate the feasibility, safety, and efficacy of Solitaire stent placement after
balloon angioplasty for the treatment of complex symptomatic intracranial atherosclerotic …

Background: For patients with symptomatic intracranial artery stenosis (sICAS),
endovascular treatment has been shown to be feasible and safe in recent studies. However …

Objectives Symptomatic intracranial vertebrobasilar artery stenosis (IVBS) carries a high
annual risk of recurrent stroke. Endovascular therapy was a promising technique but recent …

Objective To compare the technical and 1-year clinical outcome in balloon-mounted versus
self-expanding stenting for symptomatic severe stenosis of the middle cerebral artery …

Objective Stent placement is a feasible approach worldwidely for patients with symptomatic
intracranial artery stenosis (sICAS) and hemodynamic impairment (HI) who are at high risk …

Introduction: Whether adding percutaneous transluminal angioplasty and stenting (PTAS) to
background medical treatment is effective for decreasing the incidence of stroke or death in …